| FDXR regulates TP73 tumor suppressor via IRP2 to modulate aging and tumor suppression | None |
| MCL1 binds and negatively regulates the transcriptional function of tumor suppressor p73 | None |
| overexpression in malignant and premalignant lesions suggests role in oncogenic process in cervical epithelium | cervical, |
| Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. | HNSC, |
| p63 and p73 expression may represent an early event in head and neck squamous carcinoma tumorigenesis and may function as oncogenes in the development of these tumors. | HNSC, |
| p73 has a role in contributing to the oncogenic potential of neuroblastoma cells (review) | neuroblastoma, |
| [Expression and prognosis significance of p73 and PCNA in laryngeal squamous cell carcinoma]. | laryngeal, |
| p73 protein positive expression may play a part in laryngeal squamous cell carcinoma progression and function as an oncogene in the development of LSCC. | laryngeal, |
| The p73-isoform-related interaction with Sp1 is the underlying mechanism of the diverse outcome on HBV core expression, suggesting a new mechanism by which oncogenic DeltaTAp73 could enhance the carcinogenic process in liver cells. | liver, |
| The molecular mechanisms accounting for the oncogenic role of DeltaNp73 in hepatocellular carcinoma, were investigated. | liver, |
| DeltaNp73 behaves as an oncogene that targets p53 that might explain why DeltaNp73 upregulation may be selected for during tumorigenesis | None |
| reported overexpression of p73alpha in certain tumor types, and this study_s findings that p73alpha exerts anti-apoptotic functions, indicate a potential oncogenic activity for p73 | None |
| The overall data argue against an oncogenic role for isoform DeltaNp73. | None |
| findings show that deltaN-p73 is a transcriptional target of the PML/RARalpha oncogene; this results in the transcriptional repression of deltaN-p73 | None |
| Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo. | None |
| upregulation of DeltaTAp73 isoforms was associated with shortened OS, increase in proliferation, and drug resistance confirms their oncogenic role and plausible value as prognostic markers. | None |
| Knockdown of p73 inhibits proto-oncogene, pleomorphic adenoma gene-like 2-induced cell cycle block and Bax expression. | None |
| reported that DeltaNp73 exhibits anti-apoptotic and oncogenic properties through inhibition of p53 and p73 proteins | None |
| The p73 gene may play a role as oncogene in Wilms_ tumor patients with p73 gene promoter methylation and mRNA overexpression is associated with promoter methylation status of p73 gene. | None |
| [Relationship between mRNA expression and promoter methylation status of p73 gene in peripheral blood among children with Wilms tumor]. | None |